C4 Therapeutics Inc. (CCCC)
NASDAQ · Healthcare
C4 Therapeutics Inc. Cash on Hand 2021–2025
C4 Therapeutics Inc. annual/quarterly cash on hand history from 2021 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- C4 Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 74.6M, a 34.42% increase year-over-year.
- C4 Therapeutics Inc. cash on hand for 2025 were 74.6M, a 34.42% increase from 2024.
- C4 Therapeutics Inc. cash on hand for 2024 were 55.5M, a 56.16% decrease from 2023.
- C4 Therapeutics Inc. cash on hand for 2023 were 126.6M, a 325.46% increase from 2022.
- C4 Therapeutics Inc. cash on hand for 2022 were 29.8M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| C4 Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $75 |
| 2024 | $55 |
| 2023 | $127 |
| 2022 | $30 |
| 2021 | $76 |
| C4 Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $75 |
| 2024-12-31 | $55 |
| 2023-12-31 | $127 |
| 2022-12-31 | $30 |
| 2021-12-31 | $76 |
C4 Therapeutics Inc. Cash on Hand — FAQ
C4 Therapeutics Inc. (CCCC) cash on hand over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CCCC's cash on hand history?
The chart and table above show C4 Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.